Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Henry, J
doi: 10.1016/j.jstrokecerebrovasdis.2018.05.039 78 HeppnerK
Payers are starting to expand coverage criteria as real-world outcomes and employer demand for obesity care increases
Mild side effects like soreness at the injection site may occur but resolve quickly
Specifically, individuals with a body mass index (BMI) of 30 or higher (obese), or a BMI of greater than 27 and less than 30 (overweight) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol, may qualify for semaglutide treatment
US$ 22.29
US$ 27.29
US$ 22.14
US$ 22.85
:max_bytes(150000):strip_icc()/Health-GettyImages-2112991427-c2c4d692054b4ff6933f01fc6c5be06c.jpg)
